Cancer Core Europe Lecture: Prof. Kamila Czene, Karolinska Institutet

Welcome to the next Cancer Core Europe (CCE) Lecture, hosted by Karolinska Institutet, Sweden:

Genetic and mammographic determinants of breast cancer prognosis

Professor Kamila Czene, Department of Medical Epidemiology & Biostatistics, KI

 Friday, March 24, 2023 ‒ Time: 14.00 CET

https://ki-se.zoom.us/j/62002738051 

Abstract
In Sweden, every sixth hour a woman dies from breast cancer. Mammography screening was introduced to decrease death from breast cancer through early detection of the disease. Still, currently no tool exists that addresses women who attend mammography screening and still develop aggressive breast cancers not detected in screening. Among breast cancer patients, approximately one out of three women develops a recurring disease, often even later than 10 years since diagnosis. An early response tool is therefore needed to enable early identification of women at increased risk of late recurrent disease. Overall, it is important to understand patient characteristics that - in addition to tumor characteristics - define breast cancer aggressiveness and treatment response. This presentation focuses on studies of genetic and mammographic determinants of breast cancer prognosis, while taking into consideration a broad spectrum of other attributes.

What is Cancer Core Europe (CCE)?
Cancer Core Europe is a consortium of seven leading cancer centres (www.cancercoreeurope.eu). CCEs members are driven by a strong will to reshape the cancer research model to ultimately increase the European Union’s competitiveness as a place to conduct cutting-edge research that’s translated to the clinic to deliver more personalized medicine.

What is the content and aim of the CCE Lecture?
The CCE Lecture series is a CCE-internal event, which educates and informs about state of the art research within the seven centers and is aimed to increase awareness among partners about each other’s activities and potential for collaboration.